Trials / Completed
CompletedNCT00159692
Amlodipine Diabetic Hypertension Efficacy Response Trial
A Multi-Center, Randomized, Double-Blind, Double-Dummy Study Evaluating The Safety and Efficacy Of The Addition Of Amlodipine To Quinapril Or Losartan In The Treatment Of Diabetic Hypertensive Subjects
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 739 (actual)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 30 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the percentage of subjects that reach the diabetic hypertensive blood pressure goal of \<130/80 with amlodipine versus placebo in subjects initially treated with quinapril or losartan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amlodipine |
Timeline
- Start date
- 2003-03-01
- Completion
- 2005-08-01
- First posted
- 2005-09-12
- Last updated
- 2021-01-28
Source: ClinicalTrials.gov record NCT00159692. Inclusion in this directory is not an endorsement.